 |
Previous Article | Next Article 
The Journal of Neuroscience, October 15, 2000, 20(20):7510-7516
Mechanism of Interleukin-1- and Tumor Necrosis Factor
-Dependent Regulation of the 1-Antichymotrypsin Gene
in Human Astrocytes
Tomasz
Kordula1,
Marcin
Bugno1,
Russell E.
Rydel2, and
James
Travis3
1 Institute of Molecular Biology, Jagiellonian
University, 31-120 Kraków, Poland, 2 Elan
Pharmaceuticals, South San Francisco, California 94080, and
3 Department of Biochemistry and Molecular Biology, The
University of Georgia, Athens, Georgia 30602
The expression of 1-antichymotrypsin (ACT) is
significantly enhanced in affected brain regions in Alzheimer's
disease. This serine proteinase inhibitor specifically colocalizes with
filamentous -amyloid deposits and recently has been shown to
influence both formation and destabilization of -amyloid fibrils. In
the brain, ACT is expressed in astrocytes, and interleukin-1
(IL-1), tumor necrosis factor (TNF), oncostatin M (OSM), and
IL-6/soluble IL-6 receptor complexes control synthesis of this
inhibitor. Here, we characterize a molecular mechanism responsible for
both IL-1 and TNF-induced expression of ACT gene in astrocytes. We
identify the 5' distal IL-1/TNF-responsive enhancer of the ACT gene
located 13 kb upstream of the transcription start site. This
413-bp-long enhancer contains three elements, two of which bind nuclear
factor kB (NF-kB) and one that binds activating protein 1 (AP-1). All of these elements contribute to the full responsiveness of the ACT gene
to both cytokines, as determined by deletion and mutational analysis.
The 5' NF-kB high-affinity binding site and AP-1 element contribute
most to the enhancement of gene transcription in response to TNF and
IL-1. In addition, we demonstrate that the 5' untranslated region of
the ACT mRNA does not contribute to cytokine-mediated activation.
Finally, we find that overexpression of the NF-kB inhibitor (IkB)
totally inhibits any activation mediated by the newly identified
IL-1/TNF enhancer of the ACT gene.
Key words:
1-antichymotrypsin; Alzheimer's disease; IL-1; TNF; regulation; transcription; enhancer; NF-kB; AP-1
Copyright © 2000 Society for Neuroscience 0270-6474/00/20207510-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Sama, D. M. Mathis, J. L. Furman, H. M. Abdul, I. A. Artiushin, S. D. Kraner, and C. M. Norris
Interleukin-1{beta}-dependent Signaling between Astrocytes and Neurons Depends Critically on Astrocytic Calcineurin/NFAT Activity
J. Biol. Chem.,
August 8, 2008;
283(32):
21953 - 21964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Padmanabhan, M. Levy, D. W. Dickson, and H. Potter
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons
Brain,
November 1, 2006;
129(11):
3020 - 3034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Gopalan, K. M. Wilczynska, B. S. Konik, L. Bryan, and T. Kordula
Nuclear Factor-1-X Regulates Astrocyte-specific Expression of the {alpha}1-Antichymotrypsin and Glial Fibrillary Acidic Protein Genes
J. Biol. Chem.,
May 12, 2006;
281(19):
13126 - 13133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Gopalan, K. M. Wilczynska, B. S. Konik, L. Bryan, and T. Kordula
Astrocyte-specific Expression of the {alpha}1-Antichymotrypsin and Glial Fibrillary Acidic Protein Genes Requires Activator Protein-1
J. Biol. Chem.,
January 27, 2006;
281(4):
1956 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Uddin, H. H. Garcia, R. H. Gilman, A. E. Gonzalez, and J. S. Friedland
Monocyte-Astrocyte Networks and the Regulation of Chemokine Secretion in Neurocysticercosis
J. Immunol.,
September 1, 2005;
175(5):
3273 - 3281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hou, M. Eren, C. A. Painter, J. W. Covington, J. D. Dixon, J. A. Schoenhard, and D. E. Vaughan
Tumor Necrosis Factor {alpha} Activates the Human Plasminogen Activator Inhibitor-1 Gene through a Distal Nuclear Factor {kappa}B Site
J. Biol. Chem.,
April 30, 2004;
279(18):
18127 - 18136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kannan-Thulasiraman and D. J. Shapiro
Modulators of Inflammation Use Nuclear Factor-kappa B and Activator Protein-1 Sites to Induce the Caspase-1 and Granzyme B Inhibitor, Proteinase Inhibitor 9
J. Biol. Chem.,
October 18, 2002;
277(43):
41230 - 41239.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|